127 related articles for article (PubMed ID: 38635879)
1. Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs.
Chang M; Gao F; Gnawali G; Xu H; Dong Y; Meng X; Li W; Wang Z; Lopez B; Carew JS; Nawrocki ST; Lu J; Zhang QY; Wang W
J Med Chem; 2024 May; 67(9):7301-7311. PubMed ID: 38635879
[TBL] [Abstract][Full Text] [Related]
2. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
González-Gualda E; Pàez-Ribes M; Lozano-Torres B; Macias D; Wilson JR; González-López C; Ou HL; Mirón-Barroso S; Zhang Z; Lérida-Viso A; Blandez JF; Bernardos A; Sancenón F; Rovira M; Fruk L; Martins CP; Serrano M; Doherty GJ; Martínez-Máñez R; Muñoz-Espín D
Aging Cell; 2020 Apr; 19(4):e13142. PubMed ID: 32233024
[TBL] [Abstract][Full Text] [Related]
3. Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation.
Chang M; Dong Y; Xu H; Cruickshank-Taylor AB; Kozora JS; Behpour B; Wang W
Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202315425. PubMed ID: 38233359
[TBL] [Abstract][Full Text] [Related]
4. Galactose-modified duocarmycin prodrugs as senolytics.
Guerrero A; Guiho R; Herranz N; Uren A; Withers DJ; Martínez-Barbera JP; Tietze LF; Gil J
Aging Cell; 2020 Apr; 19(4):e13133. PubMed ID: 32175667
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
[TBL] [Abstract][Full Text] [Related]
6. Chemical Strategies for the Detection and Elimination of Senescent Cells.
García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence imaging and senolysis monitoring in cancer therapy based on a β-galactosidase-activated aggregation-induced emission luminogen.
Cen P; Cui C; Huang J; Chen H; Wu F; Niu J; Zhong Y; Jin C; Zhu WH; Zhang H; Tian M
Acta Biomater; 2024 Apr; 179():340-353. PubMed ID: 38556136
[TBL] [Abstract][Full Text] [Related]
8. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice.
Cai Y; Zhou H; Zhu Y; Sun Q; Ji Y; Xue A; Wang Y; Chen W; Yu X; Wang L; Chen H; Li C; Luo T; Deng H
Cell Res; 2020 Jul; 30(7):574-589. PubMed ID: 32341413
[TBL] [Abstract][Full Text] [Related]
9. Effects and Related Mechanisms of the Senolytic Agent ABT-263 on the Survival of Irradiated A549 and Ca9-22 Cancer Cells.
Sato K; Iwasaki S; Yoshino H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948029
[TBL] [Abstract][Full Text] [Related]
10. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the discovery of senolytics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
[TBL] [Abstract][Full Text] [Related]
12. Senescence-associated β-galactosidase in subcutaneous adipose tissue associates with altered glycaemic status and truncal fat in severe obesity.
Rouault C; Marcelin G; Adriouch S; Rose C; Genser L; Ambrosini M; Bichet JC; Zhang Y; Marquet F; Aron-Wisnewsky J; Poitou C; André S; Dérumeaux G; Guerre-Millo M; Clément K
Diabetologia; 2021 Jan; 64(1):240-254. PubMed ID: 33125520
[TBL] [Abstract][Full Text] [Related]
13. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
14. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Akinboye ES; Rosen MD; Bakare O; Denmeade SR
Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation.
Zhu Y; Ye X; Wu Y; Shen H; Cai Z; Xia F; Min W; Hou Y; Wang L; Wang X; Xiao Y; Yang P
J Med Chem; 2024 May; 67(9):7283-7300. PubMed ID: 38676656
[TBL] [Abstract][Full Text] [Related]
17. [Senolytic effects on dental pulp stem cell's proliferation and differentiation during long-term expansion].
Wang GY; Liao L; Tian WD
Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 May; 59(5):444-452. PubMed ID: 38636998
[No Abstract] [Full Text] [Related]
18. Suicide gene therapy using E. coli beta-galactosidase.
Farquhar D; Pan BF; Sakurai M; Ghosh A; Mullen CA; Nelson JA
Cancer Chemother Pharmacol; 2002 Jul; 50(1):65-70. PubMed ID: 12111114
[TBL] [Abstract][Full Text] [Related]
19. A versatile drug delivery system targeting senescent cells.
Muñoz-Espín D; Rovira M; Galiana I; Giménez C; Lozano-Torres B; Paez-Ribes M; Llanos S; Chaib S; Muñoz-Martín M; Ucero AC; Garaulet G; Mulero F; Dann SG; VanArsdale T; Shields DJ; Bernardos A; Murguía JR; Martínez-Máñez R; Serrano M
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30012580
[TBL] [Abstract][Full Text] [Related]
20. Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells.
Morsli S; Doherty GJ; Muñoz-Espín D
Mech Ageing Dev; 2022 Mar; 202():111618. PubMed ID: 34990647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
